Fill Profile Development Lowers Reject Rate for Lyophilized Product

See how smarter filling saved a biologic from a double-digit reject rate. 

A small amount of liquid left on the vial wall can mean a costly reject, especially when a high-value API is on the line. For one client’s high-value biologic, that meant reject rates reaching as high as 13% per batch.

In this case study, you’ll learn how Jubilant HollisterStier’s technical experts:

  • Identified the root cause of residue-driven rejects during tech transfer
  • Reduced the defect rate from product residue to 1% or less
  • Improved batch yield and conserved a high-value API  
Lyophilizer

Related Posts

Case Study: FTZ Subzone for API Clearance

Case Study: FTZ Subzone for API Clearance

FTZ Subzone for API Clearance Challenge A customer needed to change from a domestically sourced API (active pharmaceutical ingredient) to an alternative, foreign-made API for a commercial product while avoiding any disruption to patient supply during the switch....